Association Between Antibiotic Resistance, Biofilm Formation, and Virulence Gene Profiles in Clinical Isolates of Klebsiella pneumoniae
محورهای موضوعی : Biotechnological Journal of Environmental Microorganisms
Hasanain Mohammed Madhloom Aldhalemi
1
,
Ashraf Kariminik
2
1 - Department of Microbiology, SR.C., Islamic Azad University, Tehran, Iran
2 - Department of Microbiology, Ke.C., Islamic Azad University, Kerman, Iran
کلید واژه: Klebsiella pneumoniae, antibiotic resistance, biofilm formation, virulence genes,
چکیده مقاله :
Klebsiella pneumoniae is a leading cause of healthcare-associated infections, increasingly characterized by multidrug resistance and enhanced virulence. This study aimed to investigate the interplay between antibiotic resistance, biofilm formation, and virulence gene profiles among clinical isolates of Klebsiella pneumoniae in Tehran, Iran. Clinical confirmed isolates were recovered from urine, wound, blood, catheter, and respiratory specimens. Antimicrobial susceptibility testing revealed alarming resistance rates: 100% to imipenem, ~80% to ampicillin and cefotaxime, and 69.23% were ESBL producers. Notably, a significant association was found between the hypervirulent Klebsiella pneumoniae (hvKp) phenotype and ESBL production (P = 0.003), indicating the emergence of convergent strains combining resistance and virulence. Phenotypic assays showed that 76% of isolates were capable of biofilm formation. Molecular analysis revealed high prevalence of key virulence genes: mrkA (53.84%), wzm (46.15%), pgaA (34.61%), and wbbM (23.07%). Strong positive correlations were observed between wbbM and both wzm (r = 0.734) and pgaA (r = 0.549), as well as between mrkA and wbbM (r = 0.458), suggesting synergistic roles in biofilm development. hvKp isolates were predominantly recovered from respiratory samples (66.66%), whereas classical Klebsiella pneumoniae (cKp) dominated urinary and bloodstream sources. These findings underscore a concerning convergence of carbapenem resistance, hypervirulence, and robust biofilm-forming capacity in clinical Klebsiella pneumoniae isolates in Iran. Such strains pose a serious therapeutic challenge and highlight the urgent need for enhanced surveillance, rapid diagnostics, and alternative treatment strategies targeting virulence and biofilm mechanisms.
Klebsiella pneumoniae is a leading cause of healthcare-associated infections, increasingly characterized by multidrug resistance and enhanced virulence. This study aimed to investigate the interplay between antibiotic resistance, biofilm formation, and virulence gene profiles among clinical isolates of Klebsiella pneumoniae in Tehran, Iran. Clinical confirmed isolates were recovered from urine, wound, blood, catheter, and respiratory specimens. Antimicrobial susceptibility testing revealed alarming resistance rates: 100% to imipenem, ~80% to ampicillin and cefotaxime, and 69.23% were ESBL producers. Notably, a significant association was found between the hypervirulent Klebsiella pneumoniae (hvKp) phenotype and ESBL production (P = 0.003), indicating the emergence of convergent strains combining resistance and virulence. Phenotypic assays showed that 76% of isolates were capable of biofilm formation. Molecular analysis revealed high prevalence of key virulence genes: mrkA (53.84%), wzm (46.15%), pgaA (34.61%), and wbbM (23.07%). Strong positive correlations were observed between wbbM and both wzm (r = 0.734) and pgaA (r = 0.549), as well as between mrkA and wbbM (r = 0.458), suggesting synergistic roles in biofilm development. hvKp isolates were predominantly recovered from respiratory samples (66.66%), whereas classical Klebsiella pneumoniae (cKp) dominated urinary and bloodstream sources. These findings underscore a concerning convergence of carbapenem resistance, hypervirulence, and robust biofilm-forming capacity in clinical Klebsiella pneumoniae isolates in Iran. Such strains pose a serious therapeutic challenge and highlight the urgent need for enhanced surveillance, rapid diagnostics, and alternative treatment strategies targeting virulence and biofilm mechanisms.
1. Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Annals of clinical microbiology and antimicrobials. 2020;19(1):1.
2. Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiology and molecular biology reviews. 2016;80(3):629-61.
3. Sarojamma V, Ramakrishna V. Prevalence of ESBL‐producing Klebsiella pneumoniae isolates in tertiary care hospital. International Scholarly Research Notices. 2011;2011(1):318348.
4. Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2014;3(3):743-58.
5. Riwu KHP, Effendi MH, Rantam FA. A Review of Extended Spectrum β-Lactamase (ESBL) Producing Klebsiella pneumoniae and Multidrug Resistant (MDR) on Companion Animals. Systematic Reviews in Pharmacy. 2020;11(7).
6. Kidd TJ, Mills G, Sá‐Pessoa J, Dumigan A, Frank CG, Insua JL, et al. A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO molecular medicine. 2017;9(4):430-47.
7. Mirafzali Z, Marhamatizadeh MH, Kariminik A, Habibi GH. Prevalence of Salmonella in Poultry Slaughterhouses of Kerman, Iran. Avicenna Journal of Clinical Microbiology and Infection. 2024;11(4):171-6.
8. Falih AM, Kariminik A, Rokhbakhsh ZF. Assessment of Antibiotic resistance pattern in clinical Acinetobacter baumannii carrying biofilm formation genes. 2024.
9. Abdulrahman S, Rokhbakhsh Zamin F, Kariminik A. Antibiotic resistance pattern and frequency of biofilm producing genes in Escherichia coli isolates from nosocomial infections in Tehran in 2023. International Journal of Molecular and Clinical Microbiology. 2024;14(1):2039-45.
10. Li L, Gao X, Li M, Liu Y, Ma J, Wang X, et al. Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies. Frontiers in Cellular and Infection Microbiology. 2024;14:1324895.
11. Beckman IV RL, Cella E, Azarian T, Rendueles O, Fleeman RM. Diverse polysaccharide production and biofilm formation abilities of clinical Klebsiella pneumoniae. npj Biofilms and Microbiomes. 2024;10(1):151.
12. Zeynali Kelishomi F, Amereh S, Ghayyaz F, Kazemzadeh Anari R, Khanjani S, Nikkhahi F. Antimicrobial resistance patterns and virulence gene profiles of Klebsiella pneumoniae isolated from surgical site infections in Iran. Surgical Infections. 2025.
13. Rahimi S, Khakpour M, Bakht M, Ehteram H, Nikkhahi F, Saghi Sarabi H. Assessment of the last-resort antibiotics against Extended Spectrum Beta-Lactamase/carbapenemase and biofilm producer Klebsiella pneumoniae isolated from hospitalized patients in intensive care units (ICUs), Iran. Archives of Razi Institute. 2025;80(2):551-62.
14. Abd Allah RH, Samir S, Nasr SM, Ibrahim MK. Effect of Kaempferol against Biofilm Formation by Klebsiella pneumoniae Clinical Isolates. 2025.
15. Temel A, Aydın E, Kocaağa M. Associations between carbapenemase genes, biofilm formation, and virulence factors in clinical Klebsiella pneumoniae isolates from Türkiye. Molecular Biology Reports. 2025;52(1):863.
16. Murad MW, Poran GS, Baidya K, Ahsan N. Genomic Characterization of Pan‐Drug Resistant Klebsiella pneumoniae KPNW Isolated From UTI Patient in Bangladesh. MicrobiologyOpen. 2025;14(5):e70064.
